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Human-to-mosquito transmission efﬁciency
increases as malaria is controlled
Thomas S. Churcher1, Jean-Franc¸ois Trape2 & Anna Cohuet3,4
The efﬁciency of malaria transmission between human and mosquito has been shown to be
inﬂuenced by many factors in the laboratory, although their impact in the ﬁeld and how this
changes with disease endemicity are unknown. Here we estimate how human–mosquito
transmission changed as malaria was controlled in Dielmo, Senegal. Mathematical models
were ﬁt to data collected between 1990 and the start of vector control in 2008. Results show
that asexual parasite slide prevalence in humans has reduced from 70 to 20%, but that the
proportion of infectious mosquitoes has remained roughly constant. Evidence suggests that
this is due to an increase in transmission efﬁciency caused by a rise in gametocyte densities,
although the uneven distribution of mosquito bites between hosts could also contribute. The
resilience of mosquito infection to changes in endemicity will have important implications for
planning disease control, and the development and deployment of transmission-reducing
interventions.
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T
he processes governing malaria transmission are diverse
and complex. Human–mosquito transmission occurs when
blood-feeding mosquitoes ingest parasite transmission
stages (gametocytes) circulating in the peripheral blood. The
parasite undergoes sexual reproduction before invading the
midgut and developing into oocysts and ultimately sporozoites,
which migrate to salivary glands and are capable of onwards
transmission. Mosquito-feeding experiments have shown that a
wide range of host, parasite and mosquito factors inﬂuence the
likelihood that a mosquito will acquire the infection. These
include hosts anaemia1, immunity2 and drug treatment3; parasite
(gametocyte) density4, maturity5 and clone diversity6; and
mosquito size7, microbial gut ﬂora8, environment9 and immune
response10 among others. These explanatory variables are rarely
collectively measured, making it difﬁcult to predict how
transmission efﬁciency changes between locations and following
the introduction of control interventions. It is also unclear how
transmission may differ between natural infections and those
conducted with laboratory-adapted mosquitoes in controlled
conditions11, making it difﬁcult to predict the impact of these
different factors in ﬁeld settings.
Parallel human and entomological surveys provide an alter-
native method of quantifying human–mosquito transmission in
natural settings. More efﬁcient transmission represents more
mosquitoes being infected at a given endemicity. These data are
routinely collected to assess malaria prevalence and to calculate
the entomological inoculation rate (EIR, the average number of
infectious bites per person per year). Most data sets are cross-
sectional, which restricts their use for determining transmission
efﬁciency, as parameters determining sporozoite prevalence are
likely to vary from location to location. For example, the
proportion of infectious mosquitoes depends upon both the
transmission efﬁciency, but also on the length of the extrinsic
incubation period, and the mosquito death rate12. Both of these
factors are likely to vary between sites13,14. There may also be a
difference in strains of the parasite and mosquito, which may
inﬂuence vector competence11. All these processes will themselves
change endemicity, which makes it difﬁcult to ascribe changes in
the relationship between human and mosquito prevalence to
changes in transmission efﬁciency. Many of these problems
can be overcome using longitudinal studies, where the biology
and epidemiology of the parasite and vector are likely to be
more consistent. Diagnostic sensitivity and mosquito-trapping
techniques are also likely to be less variable increasing the
precision of results.
The Dielmo Project in Senegal started in 1990 and has
regularly estimated human and mosquito prevalence in the same
village for the last 23 years15,16. These data provide a unique data
set to test whether human–mosquito transmission efﬁciency has
changed as malaria has been controlled. A number of factors
make this site particularly amenable to this type of analysis. First,
the mosquito age distribution (as measured by parity) has
remained roughly constant between 1990 and the introduction of
insecticide-treated nets in July 2008. During this 18-year period
B50% of the population used untreated bednets16. Although
these may have some impact on mosquito mortality17, the
consistent age distribution makes it unlikely that any variability in
sporozoite prevalence is caused by changes in mosquito survival.
Vector density has also remained broadly the same over the
period, although there is some variability between years. If it is
assumed that the length of the extrinsic incubation period has
remained constant over time (as annual temperatures have
remained broadly the same18), then it seems reasonable to ascribe
changes in the relationship between human and mosquito
infection to changes in the human–mosquito transmission
probability. Second, good clinical management of cases has
reduced malaria endemicity (as measured by asexual parasite
slide prevalence, subsequently referred to as prevalence)
substantially16. In 1990, malaria prevalence in the village was
68%; in 2007, this had reduced to 30%. The gradual reduction
allows the investigation of how transmission efﬁcacy changes as
the disease is progressively controlled. Third, malaria prevalence
is relatively consistent throughout the year. Seasonality in
transmission increases the variability in the sporozoite
prevalence, so changes in human–mosquito transmission will be
easier to detect in perennial sites. Although there are seasonal
ﬂuctuations in mosquito abundance, their regularity and the
consistent timing of data collection should reduce variability and
bias. Lastly, the presence of two different groups of vectors
Anopheles gambiae sensu lato and Anopheles funestus allows two
estimates of the transmission probability and facilitates a
comparison between species.
Transmission reduction is an integral part of efforts to control
and eliminate malaria19. Understanding how human–mosquito
transmission changes as the disease is successfully controlled will
be essential to plan interventions accurately and evaluate the
public health impact of transmission-reducing drugs and
vaccines. Here we ﬁt a suite of simple mathematical models to
parallel human and entomological data to estimate how
transmission efﬁciency changes with malaria prevalence in the
village of Dielmo between 1990 and 2008. Estimates of human
and mosquito infection prevalence are uncertain, so Bayesian
techniques are used to accurately account for measurement
error and statistically determine whether human–mosquito
transmission changes with malaria prevalence. Results indicate
that as malaria has been successfully controlled transmission
efﬁciency has increased, possibly through an increase in
gametocyte density in infected individuals.
Results
Temporal trends. Malaria prevalence decreases signiﬁcantly
between 1990 and 2008 (Fig. 1a). During this time, the proportion
of infectious mosquitoes either remains constant (A. funestus)
or increases slightly (A. gambiae, Fig. 1b). Gametocyte slide
prevalence also signiﬁcantly decreases (Fig. 1a) as does the ratio
of gametocyte prevalence to asexual parasite prevalence
(Supplementary Fig. 1). The size and age distribution of the
mosquito population (as measured by parity) remains roughly
constant (Fig. 1c,d), suggesting that human–mosquito transmis-
sion has become increasingly efﬁcient to enable the high level of
mosquito infection to be maintained. Simple statistical analyses of
the broad temporal trends are presented in Supplementary Fig. 1.
Changes in human–mosquito transmission. To statistically
determine whether transmission efﬁciency varies with prevalence,
a set of nested mathematical models were ﬁt to parallel human
and mosquito infection data. Allowing human–mosquito trans-
mission probability to change with asexual parasites prevalence
(as measured by microscopy) signiﬁcantly improved model ﬁt
(Supplementary Table 1). Different functional forms for the
relationship between prevalence and transmission probability
were statistically compared, with a linear relationship that allowed
the two mosquito species to have different transmission prob-
abilities giving the most parsimonious ﬁt. The best-ﬁt model
indicates that when 70% of villagers have slide-detectable asexual
parasites,B5% of mosquitoes biting an infected host will develop
sporozoites. Reducing malaria prevalence to 20% increases the
transmission probability toB14% (Fig. 2a,b). A similar pattern is
seen in both A. gambiae and A. funestus, indicating that the result
is consistent across mosquito species. The analysis was repeated
using the prevalence of gametocyte (transmission stages) instead
of prevalence of asexual parasites. Again a similar pattern was
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Figure 1 | Summary of the Dielmo data between 1990 and the start of vector control in July 2008. (a) The changes in Plasmodium falciparum
prevalence of asexual parasites (purple) and gametocytes (green) in the enrolled population as measured by microscopy. (b) The percentage of Anopheles
gambiae s.l. (blue) and A. funestus (red) with salivary gland sporozoites. (c) The parity of A. gambiae s.l. (blue) and A. funestus (red) (data were only available
for certain months between 1990–1994 and 2001–2008, see Methods). (d) The cumulative monthly biting rate of A. gambiae s.l. (blue) and A. funestus
(red). In all panels horizontal lines show the mean over the years (lines are omitted when there is missing data for the period). The changes in the drugs
used for ﬁrst-line therapy are shown at the top of the ﬁgure, be it quinine (grey), chloroquine (orange), amodiaquine plus sulphadoxine-pyrimethamine
(Amþ SP, pink) or amodiaquine plus artesunate (AmþAr, yellow). In addition to the treatment of cases, there was no other use of antimalarials but for
intermittent preventive treatment for pregnant women (one dose of SP quarterly from 2004).
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Figure 2 | Best-ﬁt models. (a) The relationship between the proportion of mosquitoes with salivary gland sporozoites and the prevalence of asexual
parasites in the human population. Each point shows human and entomological surveys conducted during the same month. Blue points are Anopheles
gambae s.l. and red A. funestus. Thick lines give the best-ﬁt model for each mosquito species. (b) The change in the human–mosquito transmission efﬁciency
(expressed as a proportion) with the proportion of asexual parasites in the human population. Blue line is for A. gambae s.l. and red for A. funestus.
(c) The relationship between the mean gametocyte density in gametocyte-positive patients (per microlitre of blood, as detected by microscopy) and the
proportion of patients with asexual parasites. In all plots horizontal and vertical lines denote the 95% conﬁdence intervals around point estimates while the
thick solid lines and shaded areas show the median and the 95% Bayesian credibility intervals for the posterior distribution, respectively.
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observed, with models that allow transmission efﬁcacy to change
with gametocyte prevalence giving signiﬁcantly better ﬁts
(Supplementary Table 1). The increase in transmission efﬁciency
could be explained in part by an increase in the number of
gametocytes in patients where they were detectable by micro-
scopy (Fig. 2c). In gametocyte-positive hosts, the density of
gametocytes doubled as asexual parasite slide prevalence dropped
from 70 to 40%. A variety of frontline therapies have been used
over the years, starting with quinine before switching to chlor-
oquine (1994), amodiaquine plus sulphadoxine-pyrimethamine
(Amþ Sp, 2003) and ﬁnally amodiaquine plus artesunate
(AmþAr, 2006). Chloroquine treatment has been shown to
induce gametocytogenesis and increase mosquito infection20,
particularly in areas where the parasite has developed drug
resistance21. To see whether the change in transmission
probability and gametocyte density was independent of the
frontline therapy, the analysis was repeated for each treatment
regimen separately. Results are consistent across all the four
treatment periods, with each showing increasing human–
mosquito transmission and gametocyte density as malaria
prevalence falls (Supplementary Fig. 2). The model that allowed
vector mortality to change relative to one another did not
improve the ﬁt, suggesting that the baseline parameters were
sufﬁciently accurate.
The change in transmission efﬁciency complicates the relation-
ship between disease prevalence and the human force of infection
(as measured by EIR). Linear regression is unable to detect a
signiﬁcant association between prevalence and EIR, either with all
data analysed together or separately according to frontline
treatment (Fig. 3). There was a positive correlation between
monthly human biting rates and prevalence (Fig. 3a), which
appears to counteract the observed changes in the human–
mosquito transmission probability so that there is no discernible
change in EIR with prevalence (Fig. 3b).
Heterogeneous biting. A possible cause for the relationship
between human and mosquito infection could be the uneven
distribution of mosquito bites across the human population
(often referred to as heterogeneous biting or hotspots of trans-
mission). Evidence suggests that in some locations a core group
of the human population receive a substantial proportion of
mosquito bites (for example, up to 80% of the bites might be
taken on just 20% of the population22). This core group will have
a higher probability of having malaria and is more likely to
remain infected if prevalence in the overall population falls. The
majority of mosquitoes will be infected by the core group, so
although the prevalence of human infection outside the core
group may go down, these hosts are bitten relatively rarely so they
will have a smaller impact on the overall proportion of infected
mosquitoes. Mosquito infection will therefore decline at a slower
rate the more heterogeneous the biting is. The phenomenon is
illustrated with a simple mathematical model presented in Fig. 4.
This suggests that there needs to be substantial biting
heterogeneity for mosquito infection to remain constant for the
range of endemicities observed in Dielmo (that is, 480% of the
bites might be taken on 20% of hosts). The basic reproductive
number, R0, is deﬁned as the average number of infections caused
by an infection in an uninfected population, and is widely used as
a measure of malaria transmission intensity12. Figure 4 illustrates
that in areas with high biting heterogeneity a very high R0 is
required to achieve a slide prevalence of 70% observed at the start
of the study. This is because most of the mosquito bites are
concentrated on the core group, so there must be very efﬁcient
transmission (for example, a high number of mosquitoes) for
those who are bitten relatively rarely to become infected. The
simple model indicates that at the highest level of biting
heterogeneity (80% of bites on 20% of hosts) there must have
been a 99.6% reduction in R0 over the course of the study for slide
prevalence to have dropped from 70 to 20%. For lower levels of
biting heterogeneity (40% of bites on 20% of hosts) this reduces to
a B80% reduction in R0.
It is unclear exactly what the degree of biting heterogeneity is
in Dielmo, as no speciﬁc study to address this has been carried
out. The small geographical area, homogeneity in type of housing
and the permanent river running beside the village suggest that
heterogeneity may be relatively minimal. A generalized linear
mixed model (GLMM) was ﬁt to the human data to determine
whether some hosts were slide positive more than others.
Examination of the individual random-effects estimates of the
model suggest that there is relatively minimal heterogeneity in the
probability of being slide positive (with the s.d. of the intercept
being 0.86, Supplementary Fig. 3). As an illustration, the model
predicts that in the 10- to 14-year age group in the last quarter of
2007 when malaria prevalence is 23%, the 20% of hosts who are
the most likely to be infected accounted for only 37% of slide-
positive infections (Supplementary Fig. 3).
Discussion
Transmission between human and mosquito is a dynamic process
that may become more efﬁcient as malaria is successfully
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Figure 3 | The relationship between entomological measurements and
the proportion of the population with asexual parasites. (a) The changes
in the average number of mosquito bites per person over a month (human
biting rate) and the proportion of asexual parasites. (b) The relationship
between the average number of infectious bites received per person per
month (the entomological inoculation rate, EIR) with malaria asexual
parasite slide prevalence. In both panels, the solid grey line shows the
results of the best-ﬁt linear regression, which was used to test for an
association between the two measurements. The 76 data points showed a
signiﬁcant association between prevalence and the biting rate (estimated
by human landing catches, P¼0.013), although there was no evidence of a
relationship between malaria prevalence and EIR (P¼0.172). Closed dots
give the individual point estimates while the shaded area indicates the 95%
conﬁdence intervals around the best-ﬁt linear regression.
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controlled. There are many possible reasons for this trend1–10,
although the data suggest that it may be in part caused by an
increase in gametocyte density in gametocyte-positive patients.
Over the course of the study, the increase in gametocyte density is
comparable to the increase in transmission efﬁciency predicted by
the model. However, this association does not prove causality,
and other processes could have contributed to the observed result.
Prevalence declines over the study period, so any temporal
change in human, parasite or mosquito factors that inﬂuences
human–mosquito transmission could have caused the increase in
transmission.
The analysis suggests that the transmission dynamics of A.
gambiae s.l. and A. funestus are slightly different, with models that
allow the efﬁciency of transmission to vary at different rates giving
the most parsimonious ﬁt. The similarity of the lines suggests that
the change in transmission efﬁciency is driven by host factors, not
vector competence. Nevertheless, secular changes to the local
climate and environment could inﬂuence both species and therefore
cannot be discounted. A wide range of factors have been shown to
increase mosquito longevity, which would increase the number of
infectious mosquitoes. Although the parity data are incomplete,
there does not appear to be a substantial change in the age
distribution between 2001 and 2008, the time that sees the greatest
fall in prevalence (Fig. 1; Supplementary Fig. 1). Parity is an
imperfect measure of mosquito survival23, although it is unlikely to
mask the considerable increase in longevity required to explain the
observed sprozoite prevalence. For example, for A. funestus,
equation (1) indicates that mean mosquito life-expectancy would
need to be increased by41/3 (from 8.9 to 12.2 days) as prevalence
dropped from 70 to 30%, if the transmission probability remained
constant at 0.06. Temporal changes in mosquito susceptibility over
time could also be a possibility as could an increase in mosquitoes
size caused by changing larval conditions. However, this would also
likely be evident in changes in mosquito longevity (as larger
mosquitoes live for longer24), and there has been no discernible
change in local climatic conditions16. Another hypothesis, which
could explain the high mosquito infection rates seen at low malaria
prevalence, might be that infected mosquitoes were migrating into
the village from the surrounding area having fed on people with a
higher malaria prevalence. This is unlikely to be the case since
Dielmo is relatively geographically isolated, and the permanent river
provides sufﬁcient breeding sites for mosquitoes, which will reduce
their geographical range15.
Some of the apparent change in human–mosquito transmis-
sion could be ascribed to microscopy becoming increasingly
inefﬁcient at detecting infections as prevalence falls25. If this was
the case then the true drop in malaria prevalence would be less
pronounced, and transmission efﬁciency would not need to
increase so much to generate the observed sporozoite prevalence.
It has been suggested that at a slide prevalence of 20%, up to 25%
of the infectious reservoir might reside in slide-negative
individuals25. Such an underestimation would be insufﬁcient to
describe the observed patterns, indicating that some increase in
transmission efﬁcacy has been observed.
The model structure used was relatively simple and assumes
that everyone is bitten equally. In reality, biting is likely to be
more heterogeneous, with some people being bitten more than
others. This has been proposed to explain why mosquito–human
transmission becomes less efﬁcient in areas of higher endemi-
city26. A simple mathematical model is used to show that
heterogeneous biting does make the relationship between human
and mosquito infection increasingly nonlinear. This model is not
speciﬁcally parameterized for Dielmo, although it suggests that
for heterogeneous biting to be the sole cause, more than 80% of
mosquito bites will need to have been taken on 20% of the
residents. Given the geography of the village and proximity of
breeding sites, this extreme heterogeneity appears unlikely. This is
backed up by the longitudinal data, which suggesting that,
although some people are more likely to have detectable asexual
parasites than others, the degree of heterogeneity is relatively low
(although the heterogeneity in malaria-positive slides may be less
pronounced than the heterogeneity in mosquito biting due to
human superinfection). In addition, the rapid decline in malaria
prevalence caused by drug treatment makes it unlikely that
heterogeneity in biting alone could have caused the persistence of
mosquito infection. Locations with high biting heterogeneity
would require a very high reduction in R0 for prevalence to drop
from 70 to 20% (as a very high R0 is needed to achieve a high
prevalence). Mosquito density has remained roughly constant
over the period, so the observed decline in malaria prevalence is
most likely caused by a reduction in the duration of human
infectiousness16. The simple model predicts that areas with the
highest biting heterogeneity R0 would have to have decreased by
499% over the course of the study. This equates to a decrease in
the duration of infectiousness of 499%, which seems infeasible
for an area where all cases of fever receive prompt treatment. In
comparison, if there is no heterogeneity in biting then a 70%
reduction in duration of infectiousness would be sufﬁcient, which
is more in line with the changes seen following switching drug
regimens in clinical trials3. Further work is required, although it
seems likely that multiple factors including an increase in
gametocyte density and heterogenenous biting contribute to the
relationship between human and mosquito infection.
If the increase in transmission efﬁciency is caused by an
increase in gametocyte density, then the reason for this is far from
clear. It has been proposed that gametocyte concentration might
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Figure 4 | An illustration of how biting heterogeneity inﬂuences the
relationship between human and mosquito infection. The ﬁgure presents
the results of a simple mathematical model that shows how the uneven
biting of mosquitoes between hosts inﬂuences the proportion of infectious
mosquitoes and humans at endemic equilibrium. Biting heterogeneity is
investigated by varying the percentage of total bites that are taken on the
20% of the people who are bitten the most, be it 20% (that is, homogenous
biting, n¼0, red line), 40% (n¼0.405, blue line), 60% (n¼ 1.55, green
line) or 80% (n¼4.10, purple line). The points and the white numbers
within them show the model-derived basic reproduction number, R0,
required to generate that endemic equilibrium. In addition to the parameter
values outlined in the main text b¼0.05, c¼0.2, and the mosquito is
assumed to be An. funestus. Care should be taken when interpreting this
ﬁgure as the mathematical model is used as an illustration and is not
speciﬁcally parameterized for Dielmo.
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be regulated by cross-stage immunity, either through reducing
asexual parasite densities (which go on to produce gametocytes)
or through the removal of circulating gametocytes directly27,28.
There is also evidence that gametocyte-infected erythrocytes elicit
a speciﬁc immune response, which has been associated with lower
gametocyte densities29. This could explain why gametocyte
carriage is longer in children than it is in adults30, and why the
density of gametocytes relative to the total parasite concentration
increases with age31. As malaria is successfully controlled
and endemicity falls, the strength of immunity may wane and
cause the observed increase in gametocyte density. Indeed,
gametocytemia has been seen to increase as the disease is
successfully controlled in other locations32,33. For example, in
Western New Guinea, insecticide spraying and mass drug
administration in the 1950s reduced disease prevalence but
more than doubled the percentage of infections, which had
detectable gametocytes32. In the Garki Project, Nigeria
gametocyte prevalence increased in older residents to as much
as double their baseline levels after control interventions were
halted34. There was also an increase in gametocyte and asexual
parasite density in patients with detectable malaria34. Both of
these observations are consistent with the hypothesis that the
increase in transmission efﬁciency could be due to higher
gametocyte density. However, both studies indicated that the
ratio of detectable gametocytes to asexual parasites went up as the
disease was successfully controlled, which is the reverse of what
was seen in Dielmo (Supplementary Fig. 1). This could be because
in Dielmo all cases of fever are promptly treated, which is likely to
impede the appearance of parasites in subsequent cross-sectional
surveys.
The model suggests that at a given slide prevalence, the
gametocyte density was higher when the community was treated
with quinine or chloroquine than for Amþ Sp or AmþAr,
which is in accordance with our current knowledge of drug
action35. It cannot be discounted that the rise in chloroquine
resistance over the period36 could have contributed to the
increase in gametocyte density, although the similar patterns seen
with other therapies suggest that it is not the sole reason.
Transmission-reducing immunity, which targets parasite sexual
stages within the mosquito, has been shown to reduce gametocyte
infectiousness35. These immune responses are thought to be
relatively short-lived37 and therefore could also contribute to the
increase in transmission efﬁciency seen as endemicity declines
independent of any change in gametocyte density.
In highly endemic areas, mosquito–human transmission is
thought to be relatively inefﬁcient. As malaria prevalence falls,
transmission dynamics and immunoepidemiology change and
infected mosquitoes are more likely to transmit the infection26.
This is an example of a negative frequency-dependent process
that can have an important impact on parasite population
dynamics. Here we show that human–mosquito transmission is
also a negative frequency-dependent process that acts
independently of any changes in efﬁciency of mosquito–human
transmission. This could occur both at the individual level (due to
changes in gametocyte density) and at the population level (due
to heterogeneous biting). As malaria is successfully controlled and
hyper-endemic regions become meso-endemic, human–mosquito
transmission will on average become more efﬁcient and the
parasite is more likely to complete its lifecycle. This will have
important epidemiological implications as it will increase the
stability of disease and make it harder to control and eliminate.
Current mathematical models of malaria tend to either assume a
constant human–mosquito transmission parameter or one that
changes as a function of asexual parasite density38,39. Although
this may not inﬂuence equilibrium dynamics, with other
parameters accounting for the changes in the transmission
parameter, this oversimpliﬁcation might cause the impact of
control interventions to be overly optimistic.
Transmission reduction is increasingly seen as an important
component of the disease elimination agenda40. There are
currently a large number of transmission-reducing drugs and
vaccines under development that aim to reduce human–mosquito
transmission35. Many of these candidates are partially effective,
reducing transmission from a host but not halting it. The lower
efﬁciency of human–mosquito transmission in areas of higher
malaria prevalence may make these interventions more
efﬁcacious41. This should be considered when decisions about
where potential transmission-blocking vaccine candidates should
be trialled, as it is currently thought that the interruption of
transmission is more likely in areas of low transmission
intensity40,42. Those planning the use of these interventions
should be aware that transmission between man and mosquito
might be a dynamic process and that their effectiveness may
decrease as malaria is successfully controlled.
Methods
Data set. Parallel parasitological and entomological surveys from the Dielmo
project, Senegal were collated between June 1990 and June 2008. A full description
of the site and data collection methods is given elsewhere15,16. Brieﬂy, all residents
living in the village were invited to participate in a longitudinal study, which
monitored the occurrence of fever daily. Each year 490% of villagers enrolled.
Cross-sectional parasitological surveys using a think blood smear were carried out
every quarter. A total of 200 high-powered ﬁelds were examined each time, which
is assumed to correspond to B0.5 ml blood43. Results showed that at baseline
Plasmodium falciparum, P. malariae and P. ovale were endemic in Dielmo, with a
baseline prevalence of 69.3%, 20.4% and 5.5%, respectively16. For simplicity only
the P. falciparum data were analysed, as sporozoite prevalence estimates were not
available for the other species. Human landing catches were conducted at the same
time and place (two indoor and two outdoor) each month. The proportion of
infected mosquitoes was measured by dissection of the salivary glands and
epiﬂuorescence (1990–1992) or by testing the P. falciparum circumsporozoite
protein by enzyme-linked immunosorbent assay (1992–2008). Between 1990–1994
and 2001–2008 a subset of caught mosquitoes were dissected to determine parity
(the proportion of females that had laid eggs). Matching concurrent human and
entomological data (that is, conducted within the same month) gave a total of
76 time points. This comprising of a total of 26,544 blood smears, 26,152 mosquito
dissections (46% A. gambiae s.l.) out of a total 27,283 mosquitoes caught
(49% A. gambiae s.l.). An outline of the data set is given in Supplementary Table 2.
Descriptive analysis. The temporal trends in human (asexual parasite and
gametocyte) prevalence, mosquito prevalence, mosquito biting rate and parity are
assessed using GLMMs. Models with and without time (since the start of the study,
in years) as a ﬁxed effect are compared using the likelihood ratio test. Month of
data collection was included as a random effect to account for seasonality.
A binomial error structure was used for prevalence and parity data while the
number of mosquitoes caught in landing catches (averaged over person nights) was
assumed to follow a normal distribution. Full parity data were only available from
2001 to 2008, so the analysis was restricted to this period. Point estimates of the
percentage of parous mosquitoes were available from 1990 to 1995 and were
included in the ﬁgures for illustrative purposes, although care should be taken as
the number of mosquitoes dissected is likely to vary substantially. Ninety-ﬁve per
cent conﬁdence interval estimates were generated using the binomial distribution
(exact method) for prevalence data while bootstrapping methodology was used for
gametocyte density. Simple linear regression was used to determine whether the
human biting rate or EIR changed with prevalence.
To assess whether some people were slide positive more than others,
a GLMM was ﬁt to human infection data assuming a binomial error structure
(logit function) and adjusting for patient age and changes in prevalence over time.
Person age (7 groups: 0–1, 2–4, 5–9, 10–14, 15–29, 30–44, Z45 years) and month
of survey were included as categorical variables. Host identiﬁcation number was
used as a random effect allowing the variability in the individual random-effect
intercepts to give an indication of whether the same hosts are repeatedly slide
positive. The model was then used to estimate what percentage of infections were
detected in those hosts who were most infected over the course of the study.
Mathematical model. A simple mathematical model is used to estimate
human–mosquito transmission efﬁciency from survey data. Let Xi be the
proportion of humans with microscopy detectable parasites at time point i
(where i¼ 1 .. 76). Although only gametocytes are infectious to mosquitoes,
patients are initially considered positive with either asexual parasites or gameto-
cytes since sub-microscopic gametocytes are likely to contribute to transmission35.
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The proportion of infectious mosquitoes, Zi, at time point i is given by the
following equation12,
Zi ¼ ac Xið ÞXigþ ac Xið ÞXi e
ðgnÞ ½1
where a is the mosquito biting rate, g is the mosquito death rate and n is the
mosquito latent period. Parameter c(Xi) denotes the probability that a mosquito
feeding on an infected host will develop salivary gland sporozoites (conditional on
it surviving the latent period). To investigate whether transmission efﬁciency
changes with asexual parasite slide prevalence, c(Xi) is allowed to vary with Xi using
the polynomial equation,
c Xið Þ ¼ a1 þ a2Xi þ a3X2i : ½2
This ﬂexible, nonlinear function allows for both increasing and decreasing values of
c with increasing Xi, and nests both a constant transmission probability
(a2¼ a3¼ 0) or one that varies linearly with slide prevalence (a3¼ 0). It is assumed
that mosquitoes bite every 3 days, die at a constant rate and live for an average of
7.6 days (A. gambiae s.l.) or 8.9 days (A. funestus)38,44. The latent period is taken to
be 11 days.
Model ﬁtting. A suite of nested models are ﬁt to the full human and mosquito
data set and compared. Initially it is assumed that c is the same for A. gambiae s.l.
and A. funestus mosquitoes. Next, it is allowed to vary between mosquito species
generating species-speciﬁc rates of transmission. Finally, the mortality rate of
A. gambiae s.l. is also allowed to vary to see whether different (although constant)
mosquito life expectancies can describe the discrepancy between species. In all
models the constant, linear and polynomial functions for c(Xi) are tested.
All models were ﬁt using Bayesian methods to account for the considerable
measurement error. A binomial distribution is used to describe the malaria
prevalence in both humans and mosquitoes. Numerical simulation was done using
a Gibbs Markov chain Monte Carlo sampling algorithm implemented in
OpenBUGS45. Three Markov chains were initialized to assess convergence and the
ﬁrst 5,000 Markov chain Monte Carlo iterations were discarded as burn in. A total
of 10,000 iterations were used to derive the posterior distribution of parameters and
generate 95% Bayesian credible interval estimates for model ﬁts. Uniform priors
U([ 100,100]) were used for all parameters although parameter sets that gave
negative values of c were excluded. Models were compared using the deviance
information criterion46. Smaller values indicate a better ﬁt, and a difference of ﬁve
deviance information criterion units is considered to be substantial. To determine
whether the effect was independent of drug regimen the analysis was repeated for
each frontline therapy.
The relationship between gametocyte density (per 0.5 ml blood) in
gametocytemic host and slide prevalence is estimated by ﬁtting equation (2) to the
individual gametocyte counts. A zero-truncated negative-binomial distribution is
used to take into account the overdispersed nature of gametocyte count data
with the overdispersion parameter allowed to vary with an uninformative prior
U([0,10]).
Heterogeneous biting transmission dynamics model. To illustrate how the
uneven distribution of mosquito bites between hosts inﬂuences the relationship
between human and mosquito infection, a simple transmission dynamics model of
malaria12 is extended to incorporates biting heterogeneity. Following Smith et al.26,
let j denote a group of patients who receive the same number of mosquito bites and
oj be the relative number of bites they receive that is described by a gamma
distribution with a population mean of one and a variance n. If it is assumed that
there is no site ﬁdelity in mosquito biting (that is, the probability that a mosquito
bites a host is not inﬂuenced by who they have bitten previously), then the change
in xj(t), the proportion of infectious humans in group j at time t, and zj(t), the
proportion of infectious mosquitoes biting on group j at time t, is given by the
equations,
d xj
 
dt
¼maojbz 1 xj
  rxj
d zj
 
dt
¼aoj _cxj 1 zj
 
exp  ngð Þ gzj;
where m is the mosquito density per human, b denotes the mosquito-to-human
transmission probability, c is the human-to-mosquito transmission probability
(which here is assumed to be constant) and r is the human recovery rate. The mean
infectivity of mosquitoes, z, is weighted by how frequently people are bitten and is
calculated using the equation, z ¼ zjoj=:
P
j
oj. Models are run until they reach
endemic equilibrium initially assuming a mean duration of infectiousness of 50
days. Endemic equilibrium will vary according to the degree of biting heterogeneity
(n), so for each value of n the mosquito density m is adjusted to enable human
endemic prevalence to reach 70%. This value of m is then kept constant and the
mean duration of infectiousness (1/r) is then decreased to generate the range of
malaria prevalence’s observed in Diemlo. For each parameter set the basic
reproduction number R0 is calculated using equations outlined in Smith and
McKenzie12.
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